Page last updated: 2024-12-07

pd 81723

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

PD 81723: adenosine binding enhancer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122028
CHEMBL ID59532
SCHEMBL ID2780127
MeSH IDM0202258

Synonyms (46)

Synonym
(2-amino-4,5-dimethyl-3-thienyl)-(3-(trifluoromethyl)phenyl)methanone
pd-81,723
methanone, (2-amino-4,5-dimethyl-3-thienyl)(3-(trifluoromethyl)phenyl)-
HMS3267B12
HMS3394F11
NCGC00025124-01
tocris-1363
pd81723
pd 81723
HMS2052F11
(2-amino-4,5-dimethylthiophen-3-yl)(3-(trifluoromethyl)phenyl)methanone
(2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluoromethyl)phenyl]methanone
(2-amino-4,5-dimethylthien-3-yl)-[3-(trifluoromethyl)phenyl]-methanone
(2-amino-4,5-dimethyl-thiophen-3-yl)-(3-trifluoromethyl-phenyl)-methanone
bdbm50080550
CHEMBL59532 ,
pd-81723
(2-amino-4,5-dimethylthiophen-3-yl)-[3-(trifluoromethyl)phenyl]methanone
132861-87-1
A806507
smr000468734
MLS001424309
AKOS016005691
CCG-101185
FT-0643184
pd 81,723
NC00435
pd81,723
SCHEMBL2780127
DTXSID00157821
SR-01000597575-1
sr-01000597575
pd 81,723, >=98% (hplc), solid
gtpl9445
J-006233
(2-amino-4,5-dimethylthiophen-3-yl)-(3-(trifluoromethyl)phenyl)methanone
methanone, (2-amino-4,5-dimethyl-3-thienyl)[3-(trifluoromethyl)phenyl]-
HMS3676I16
n-(5-amino-pentyl)-phthalimidehcl
kkdkawkygcuogr-uhfffaoysa-n ,
HMS3412I16
BRD-K77951111-001-01-1
SB16984
P10177
CS-0025279
GLXC-25911

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" However, the same dose of PD 81,723 caused a significant leftward and upward shift of the adenosine dose-response curve for inducing atrium to His bundle interval prolongation and increased the degree of atrioventricular block caused by adenosine."( Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart.
Amoah-Apraku, B; Belardinelli, L; Bruns, RF; Lu, JY; Pelleg, A; Xu, J, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency25.05940.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
phosphopantetheinyl transferaseBacillus subtilisPotency79.43280.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency50.11870.031637.5844354.8130AID504865
TDP1 proteinHomo sapiens (human)Potency28.60660.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency22.38720.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency10.00000.011212.4002100.0000AID1030
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency25.11890.354828.065989.1251AID504847
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency31.62280.00798.23321,122.0200AID2551
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency28.18380.251215.843239.8107AID504327
lethal factor (plasmid)Bacillus anthracis str. A2012Potency15.84890.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Adenosine receptor A1Rattus norvegicus (Norway rat)Ki2,208.80000.00011.20929.9700AID1162469; AID1243884; AID363483; AID637821; AID703966
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Translocator proteinRattus norvegicus (Norway rat)Kd0.00180.00060.82834.0000AID363479
Adenosine receptor A1Rattus norvegicus (Norway rat)EC50 (µMol)14.70000.00161.04608.2000AID31264
Adenosine receptor A1Homo sapiens (human)EC50 (µMol)8.17300.00010.99169.8000AID240175; AID30293; AID390611; AID452545; AID474665
Adenosine receptor A1Homo sapiens (human)Kd0.00120.00020.46215.9000AID1162476; AID363476; AID363479
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (51)

Processvia Protein(s)Taxonomy
temperature homeostasisAdenosine receptor A1Homo sapiens (human)
response to hypoxiaAdenosine receptor A1Homo sapiens (human)
G protein-coupled adenosine receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
regulation of respiratory gaseous exchange by nervous system processAdenosine receptor A1Homo sapiens (human)
negative regulation of acute inflammatory responseAdenosine receptor A1Homo sapiens (human)
negative regulation of leukocyte migrationAdenosine receptor A1Homo sapiens (human)
positive regulation of peptide secretionAdenosine receptor A1Homo sapiens (human)
positive regulation of systemic arterial blood pressureAdenosine receptor A1Homo sapiens (human)
negative regulation of systemic arterial blood pressureAdenosine receptor A1Homo sapiens (human)
regulation of glomerular filtrationAdenosine receptor A1Homo sapiens (human)
protein targeting to membraneAdenosine receptor A1Homo sapiens (human)
phagocytosisAdenosine receptor A1Homo sapiens (human)
inflammatory responseAdenosine receptor A1Homo sapiens (human)
signal transductionAdenosine receptor A1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
cell-cell signalingAdenosine receptor A1Homo sapiens (human)
nervous system developmentAdenosine receptor A1Homo sapiens (human)
negative regulation of cell population proliferationAdenosine receptor A1Homo sapiens (human)
response to inorganic substanceAdenosine receptor A1Homo sapiens (human)
negative regulation of glutamate secretionAdenosine receptor A1Homo sapiens (human)
response to purine-containing compoundAdenosine receptor A1Homo sapiens (human)
lipid catabolic processAdenosine receptor A1Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicAdenosine receptor A1Homo sapiens (human)
positive regulation of nucleoside transportAdenosine receptor A1Homo sapiens (human)
negative regulation of neurotrophin productionAdenosine receptor A1Homo sapiens (human)
positive regulation of protein dephosphorylationAdenosine receptor A1Homo sapiens (human)
vasodilationAdenosine receptor A1Homo sapiens (human)
negative regulation of circadian sleep/wake cycle, non-REM sleepAdenosine receptor A1Homo sapiens (human)
negative regulation of apoptotic processAdenosine receptor A1Homo sapiens (human)
positive regulation of potassium ion transportAdenosine receptor A1Homo sapiens (human)
positive regulation of MAPK cascadeAdenosine receptor A1Homo sapiens (human)
negative regulation of hormone secretionAdenosine receptor A1Homo sapiens (human)
cognitionAdenosine receptor A1Homo sapiens (human)
leukocyte migrationAdenosine receptor A1Homo sapiens (human)
detection of temperature stimulus involved in sensory perception of painAdenosine receptor A1Homo sapiens (human)
negative regulation of lipid catabolic processAdenosine receptor A1Homo sapiens (human)
positive regulation of lipid catabolic processAdenosine receptor A1Homo sapiens (human)
regulation of sensory perception of painAdenosine receptor A1Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicAdenosine receptor A1Homo sapiens (human)
fatty acid homeostasisAdenosine receptor A1Homo sapiens (human)
excitatory postsynaptic potentialAdenosine receptor A1Homo sapiens (human)
long-term synaptic depressionAdenosine receptor A1Homo sapiens (human)
mucus secretionAdenosine receptor A1Homo sapiens (human)
negative regulation of mucus secretionAdenosine receptor A1Homo sapiens (human)
triglyceride homeostasisAdenosine receptor A1Homo sapiens (human)
regulation of cardiac muscle cell contractionAdenosine receptor A1Homo sapiens (human)
apoptotic signaling pathwayAdenosine receptor A1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationAdenosine receptor A1Homo sapiens (human)
negative regulation of long-term synaptic potentiationAdenosine receptor A1Homo sapiens (human)
negative regulation of long-term synaptic depressionAdenosine receptor A1Homo sapiens (human)
G protein-coupled receptor signaling pathwayAdenosine receptor A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
G protein-coupled receptor bindingAdenosine receptor A1Homo sapiens (human)
purine nucleoside bindingAdenosine receptor A1Homo sapiens (human)
protein bindingAdenosine receptor A1Homo sapiens (human)
heat shock protein bindingAdenosine receptor A1Homo sapiens (human)
G-protein beta/gamma-subunit complex bindingAdenosine receptor A1Homo sapiens (human)
heterotrimeric G-protein bindingAdenosine receptor A1Homo sapiens (human)
protein heterodimerization activityAdenosine receptor A1Homo sapiens (human)
G protein-coupled adenosine receptor activityAdenosine receptor A1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneAdenosine receptor A1Homo sapiens (human)
plasma membraneAdenosine receptor A1Homo sapiens (human)
basolateral plasma membraneAdenosine receptor A1Homo sapiens (human)
axolemmaAdenosine receptor A1Homo sapiens (human)
asymmetric synapseAdenosine receptor A1Homo sapiens (human)
presynaptic membraneAdenosine receptor A1Homo sapiens (human)
neuronal cell bodyAdenosine receptor A1Homo sapiens (human)
terminal boutonAdenosine receptor A1Homo sapiens (human)
dendritic spineAdenosine receptor A1Homo sapiens (human)
calyx of HeldAdenosine receptor A1Homo sapiens (human)
postsynaptic membraneAdenosine receptor A1Homo sapiens (human)
presynaptic active zoneAdenosine receptor A1Homo sapiens (human)
synapseAdenosine receptor A1Homo sapiens (human)
dendriteAdenosine receptor A1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (133)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1162465Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production at 100 nM in presence of 1 pM CCPA2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID390613Antagonist activity at human adenosine A1 receptor expressed in FlpIn-CHO cells assessed as inhibition of R-PIA-mediated ERK1/2 phosphorylation2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
AID474665Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
AID31087Percent remaining of radioligand [3H]CCPA binding to human adenosine A1 receptor at 10 uM2004Journal of medicinal chemistry, Jan-29, Volume: 47, Issue:3
Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.
AID1162477Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as shift in [3H}NECA binding affinity level at 1 uM2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID637820Displacement of [3H]DPCPX from recombinant human A1 adenosine receptor expressed in CHO-K1 cells at 100 uM2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID363478Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells relative to untreated control2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID243350Allosteric enhancer activity against adenosine A1 receptor2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID321391Displacement of [3H]CPX from human adenosine A1 receptor expressed in CHOK1 cells at 10 uM relative to control2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers.
AID637819Binding affinity to recombinant human A1 adenosine receptor allosteric site expressed in CHO cells assessed as potentiation of CCPA-induced [3H]DPCPX displacement at 10 uM after 90 mins relative to control2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID321390Activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as agonist-receptor ternary complex remaining by [35S]GTPgammaS binding assay2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers.
AID637812Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 1 uM after 6 mins by radioimmunoassay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID703964Allosteric enhancing activity at human adenosine A1 receptor expressed in CHO cells assessed as increase in [3H]-2-chloro-N6-cyclopentyladenosine Bmax at 10 uM after 90 mins relative to control2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID452545Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as drug level causing half maximal allosteric effect on [125I]-ABA dissociation from receptor-G protein ternary complex by dissociation kinetic binding assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
AID1061869Potentiation of CCPA-induced displacement of [3H]-DPCPX from human adenosine A1 receptor expressed in CHO cell membranes at 10 uM after 90 mins relative to CCPA-treated control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID1162469Displacement of [3H]DPCPX from adenosine A1 receptor in rat membranes2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID1061877Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production at 10 uM preincubated for 10 mins followed by forskolin challenge measured after 5 mins by scintillation counting a2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID703967Displacement of [3H]MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID1162473Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as shift in CCPA binding Ki level at 10 uM by [3H]DPCPX competition binding assay2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID363474Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in CHO cells at 10 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID474666Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells by scintillation counting relative to control2010Journal of medicinal chemistry, Apr-22, Volume: 53, Issue:8
Hybrid ortho/allosteric ligands for the adenosine A(1) receptor.
AID390610Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as stabilization of [125I]ABA-receptor-G protein ternary complex at 50 uM by dissociation kinetic assay2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
AID363471Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as cAMP level at 1 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID1061876Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production at 100 nM preincubated for 10 mins followed by forskolin challenge measured after 5 mins by scintillation counting 2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID703966Displacement of [3H]DPCPX from adenosine A1 receptor in rat membrane2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID31089Percent remaining of radioligand [3H]DPCPX binding to human adenosine A1 receptor at 10 uM2004Journal of medicinal chemistry, Jan-29, Volume: 47, Issue:3
Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.
AID276227Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation in presence of CPA at 1 uM relative to control2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID30314Inhibition of [3H]CPX binding to CHO-K cell membrane expressing human Adenosine A1 receptor2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.
AID363477Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells assessed for per milligram of protein2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID30312Ability to displace the binding of [3H]DPCPX to the ligand binding site of CHO:hA1 (human Adenosine A1 receptor) at concentration of 10 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID363480Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells assessed for per milligram of protein2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID703963Allosteric enhancing activity at human adenosine A1 receptor expressed in CHO cells assessed as increase in CCPA-induced [3H]DPCPX displacement at 10 uM after 90 mins relative to control2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID637814Displacement of [3H]DPCPX from recombinant human A1 adenosine receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID1243881Increase of [3H]-NECA affinity to human adenosine A1 receptor expressed in CHO cells at 1 uM after 45 mins by scintillation spectrometry analysis relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID276224Displacement of [3H]MRE-3008F20 from human adenosine A3 receptor expressed in CHO cells at 10 uM2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID1243884Displacement of [3H]DPCPX from adenosine A1 receptor in rat membranes2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID1061871Displacement of [3H]-DPCPX from human adenosine A1 receptor expressed in CHO-K1 cell membranes at 100 uM relative to control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID363479Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID321389Activity at human adenosine A1 receptor expressed in CHOK1 cells assessed as agonist-receptor ternary complex remaining by [35S]GTPgammaS binding assay after 10 mins2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers.
AID637811Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 0.1 uM after 6 mins by radioimmunoassay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID637818Binding affinity to recombinant human A1 adenosine receptor allosteric site expressed in CHO cells assessed as [3H]DPCPX Bmax shift at 10 uM after 90 mins relative to control2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID9630Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 10 uM concentration2000Bioorganic & medicinal chemistry letters, Sep-04, Volume: 10, Issue:17
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.
AID1243872Positive allosteric enhancement of human cloned adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 100 nM using [3H]-cAMP by scintillation counting relative to control in presence of 1 pM of CCPA2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID240175Antagonist activity against adenosine A1 receptor2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID34083Ability to displace the binding of [3H]-ZM 241385, to the ligand binding site of CHO:hA2A (human Adenosine A2A receptor) at concentration of 10 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID276229Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation in the presence of CPA relative to control2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID766683Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as inhibition of CCPA-induced cAMP production at 100 nM after 10 mins2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID1061875Displacement of [3H]-DPCPX from human adenosine A1 receptor expressed in CHO cell membranes at 10 uM by scintillation counting analysis relative to control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID31108Dissociation rate of [3H]CCPA from Adenosine A1 receptor expressing CHO cells at 10 uM as percent t1/22003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID19109Half life by its biological oxidation in presence of horse radish peroxide2004Bioorganic & medicinal chemistry letters, Feb-23, Volume: 14, Issue:4
Regioselective oxidation of 2-amino-3-aroyl-4,5-dialkylthiophenes by DMSO.
AID452549Agonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as induction of ERK1/2 phosphorylation at 10 uM relative to R-PIA2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
AID363469Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as cAMP level at 0.01 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID766678Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as increase of CCPA Ki at 10 uM after 90 mins by [3H]DPCPX radioligand binding assay2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID19110Half life by its biological oxidation in presence of human liver microsomes2004Bioorganic & medicinal chemistry letters, Feb-23, Volume: 14, Issue:4
Regioselective oxidation of 2-amino-3-aroyl-4,5-dialkylthiophenes by DMSO.
AID452547Agonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as potentiation of R-PIA-induced ERK1/2 phosphorylation at 10 uM2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
AID637810Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 0.01 uM after 6 mins by radioimmunoassay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID31088Percent remaining of radioligand [3H]DPCPX binding to human adenosine A1 receptor at 1 uM2004Journal of medicinal chemistry, Jan-29, Volume: 47, Issue:3
Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors.
AID703968Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID1243880Effect on dissociation binding rate constant of [3H]-NECA to human adenosine A1 receptor expressed in CHO cells at 1 uM after 45 mins by scintillation spectrometry analysis relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID32625Percent change in cAMP content of CHO (Chinese hamster ovary) cells expressing human Adenosine A1 receptor at 0.01 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID363473Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID766682Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID7698Ability to displace the binding of [3H]-MRE 3008-F20 to the ligand binding site of CHO:hA3 (human Adenosine receptor) at concentration of 10 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID276222Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID363483Displacement of [3H]DPCPX from adenosine A1 receptor in rat membranes2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID1162476Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as [3H]NECA affinity constant at 1 uM (Kd = 0.87 +/- 0.04 nM)2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID363484Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 100 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID1243879Effect on association binding rate constant of [3H]-NECA to human adenosine A1 receptor expressed in CHO cells at 1 uM after 45 mins by scintillation spectrometry analysis2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID31093Inhibition of antagonist [3H]CPX binding to Adenosine A1 receptor membrane at 100 uM2003Journal of medicinal chemistry, May-08, Volume: 46, Issue:10
2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications.
AID244459In vitro allosteric enhancer (AE) activity for adenosine A2A receptor at 50 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID703971Allosteric enhancing activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation at 10 uM incubated for 10 mins prior to forskolin-stimulation measured after 5 mins by competition protein2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID30319Dissociation of [3H]CCPA from Adenosine A1 receptor in CHO cells at 10 uM as percent K-12003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID32626Percent change in cAMP content of CHO (Chinese hamster ovary) cells expressing human Adenosine A1 receptor at 0.1 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID363476Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID766681Displacement of [3H]ZM 241385 from human adenosine A2A receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID1162474Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as [3H]NECA association rate at 1 uM (Rvb = 0.0183 +/- 0.0008 /nM/min)2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID9624Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 1 uM concentration2000Bioorganic & medicinal chemistry letters, Sep-04, Volume: 10, Issue:17
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.
AID1162467Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in CHO cell membranes at 10 uM2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID276226Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation in presence of CPA at 0.1 uM relative to control2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID31241Antagonistic activity expressed as percent displacement of 0.4 nM of [3H]DPCPX from adenosine A1 receptors in rat brain cortex membranes at 10 uM1999Journal of medicinal chemistry, Sep-09, Volume: 42, Issue:18
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.
AID32624Dissociation of [3H]N6-cyclohexyladenosine ([3H]CHA) from CHO-K1 membrane expressing human adenosine A1 receptor after treatment with allosteric enhancer at 100 uM and (R)-PIA2003Journal of medicinal chemistry, May-08, Volume: 46, Issue:10
2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications.
AID766680Displacement of [3H]MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID31270Enhancing activity at 10 uM PD 81,723 (100%) at Adenosine A1 receptor in rat brain cortex membranes1999Journal of medicinal chemistry, Sep-09, Volume: 42, Issue:18
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.
AID452544Allosteric modulatory activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as [125I]-ABA-receptor-G protein ternary complex remaining after 10 mins of radioligand dissociation at 50 uM by dissociation kinetic binding assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
AID1162466Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membranes at 10 uM2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID1061873Displacement of [3H]-MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cell membranes at 10 uM by scintillation counting analysis relative to control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID32628Percent change in cAMP content of CHO (Chinese hamster ovary) cells expressing human Adenosine A1 receptor at 1 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID637813Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 10 uM after 6 mins by radioimmunoassay2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID1243876Displacement of [3H]-MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID390611Modulation of human adenosine A1 receptor expressed in CHO-K1 cells assessed as allosteric effect on [125I]ABA dissociation2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
AID9617Percentage of response to 10 uM of PD-81723 on CHO cells expressing the cloned human A1-adenosine receptor at 0.1 uM concentration2000Bioorganic & medicinal chemistry letters, Sep-04, Volume: 10, Issue:17
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.
AID363481Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells relative to untreated control2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID1061872Displacement of [3H]-DPCPX from rat brain membrane adenosine A1 receptor2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID1162470Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as shift in [3H]CCPA Bmax level at 10 uM by saturation binding assay2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID363475Displacement of [3H]MRE3008F20 from human adenosine A3 receptor expressed in CHO cells at 10 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID766684Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production at 10 uM after 10 mins2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID1162468Displacement of [3H]MRE-3008-F20 from human adenosine 3 receptor expressed in CHO cell membranes at 10 uM2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID363472Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as cAMP level at 10 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID1162464Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production at 10 uM2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID1162475Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as [3H]NECA dissociation rate at 1 uM (Rvb = 0.0159 +/- 0.0004 /min)2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID703969Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID244458In vitro allosteric enhancer (AE) activity for adenosine A3 receptor at 50 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID276225Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation in presence of CPA at 0.01 uM relative to control2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID276228Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation in presence of CPA at 10 uM relative to control2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID703965Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHOK1 cells at 100 uM2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID1243875Displacement of [3H]-ZM241385 from human adenosine A2 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID1162472Allosteric enhancer activity at human adenosine A1 receptor expressed in CHO cell membranes assessed as shift in [3H]CCPA Kd level at 10 uM by saturation binding assay2014Journal of medicinal chemistry, Sep-25, Volume: 57, Issue:18
Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene.
AID637815Displacement of [3H]ZM241385 from recombinant human A2A adenosine receptor expressed in CHO cells at 10 uM after 60 mins by scintillation counting2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID30293Effective dose as dissociation of [3H]N6-cyclohexyladenosine ([3H]CHA) from CHO-K1 membrane after treatment with allosteric enhancer and (R)-PIA2003Journal of medicinal chemistry, May-08, Volume: 46, Issue:10
2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications.
AID32618Allosteric enhancer activity score measured by its ability to stabilize the agonist-receptor-G protein ternary complex at a concentration of 100 uM2002Journal of medicinal chemistry, Jan-17, Volume: 45, Issue:2
2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.
AID390612Displacement of [3H]CPX from human adenosine A1 receptor expressed in CHO-K1 cells at 50 uM2008Journal of medicinal chemistry, Oct-09, Volume: 51, Issue:19
2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
AID703970Allosteric enhancing activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation at 100 nM incubated for 10 mins prior to forskolin-stimulation measured after 5 mins by competition protei2012Journal of medicinal chemistry, Sep-13, Volume: 55, Issue:17
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor.
AID276223Displacement of [3H]ZM 241385 from human adenosine A2 receptor expressed in CHO cells at 10 uM2006Bioorganic & medicinal chemistry letters, Nov-01, Volume: 16, Issue:21
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
AID637816Displacement of [3H]MRE3008F20 from recombinant human A3 adenosine receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID637817Binding affinity to recombinant human A1 adenosine receptor allosteric site expressed in CHO cells assessed as [3H]CCPA Bmax shift at 10 uM after 90 mins relative to control2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID452546Agonist activity at human adenosine A1 receptor expressed in CHOk1 cells assessed as potentiation of R-PIA-induced ERK1/2 phosphorylation at 3 uM2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
3- and 6-Substituted 2-amino-4,5,6,7-tetrahydrothieno[2,3-c]pyridines as A1 adenosine receptor allosteric modulators and antagonists.
AID766679Allosteric enhancement of human adenosine A1 receptor expressed in CHO cells assessed as increase of [3H]CCPA Bmax at 10 uM after 90 mins2013European journal of medicinal chemistry, Sep, Volume: 67Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor.
AID244462In vitro allosteric enhancer (AE) activity for adenosine A1 receptor at 50 uM; ND is not determined2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID244457In vitro allosteric enhancer (AE) activity for adenosine A1 receptor at 50 uM2005Journal of medicinal chemistry, Aug-11, Volume: 48, Issue:16
6-aryl-8H-indeno[1,2-d]thiazol-2-ylamines: A1 adenosine receptor agonist allosteric enhancers having improved potency.
AID1243871Positive allosteric enhancement of human cloned adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation at 10 uM using [3H]-cAMP by scintillation counting relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID1243878Binding affinity to human adenosine A1 receptor expressed in CHO cells assessed as fold Ki shift of CCPA at 10 uM after 90 mins by [3H]-CCPA displacement assay relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID1243874Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells at 10 uM after 120 mins by scintillation counting2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID1061870Potentiation of [3H]CCPA binding to human adenosine A1 receptor expressed in CHO cell membranes at 10 uM after 90 mins relative to [3H]CCPA-treated control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID1061874Displacement of [3H]-ZM241385 from human adenosine A2A receptor expressed in CHO cell membranes at 10 uM by scintillation counting analysis relative to control2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor.
AID363470Activity at human recombinant adenosine A1 receptor expressed in CHO cells assessed as of cAMP level at 0.1 uM2008Journal of medicinal chemistry, Sep-25, Volume: 51, Issue:18
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor.
AID32629Percent change in cAMP content of CHO (Chinese hamster ovary) cells expressing human Adenosine A1 receptor at 10 uM2003Journal of medicinal chemistry, Feb-27, Volume: 46, Issue:5
Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.
AID1243877Binding affinity to human adenosine A1 receptor expressed in CHO cells assessed as fold Bmax shift of [3H]-CCPA at 10 uM after 90 mins by [3H]-CCPA binding assay relative to control2015European journal of medicinal chemistry, Aug-28, Volume: 101Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.
AID637821Displacement of [3H]DPCPX from A1 adenosine receptor in rat membranes2012Bioorganic & medicinal chemistry, Jan-15, Volume: 20, Issue:2
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine receptor.
AID31264Enhanced 0.5 nM [3H]CCPA dissociation from adenosine A1 receptor of rat brain cortex membranes compared to 100 uM CPA1999Journal of medicinal chemistry, Sep-09, Volume: 42, Issue:18
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1345685Human A1 receptor (Adenosine receptors)1990Molecular pharmacology, Dec, Volume: 38, Issue:6
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's20 (36.36)18.2507
2000's21 (38.18)29.6817
2010's12 (21.82)24.3611
2020's2 (3.64)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.39 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other55 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]